Invesaro

Stocks Comparison

Cardinal Health vs NU Skin Enterprises: revenue, profit, margins and growth compared

Cardinal Health brought in $254.2B of revenue in fiscal 2026, NU Skin Enterprises $1.5B in fiscal 2025. Revenue changed by +14.2% at Cardinal Health and -14.3% at NU Skin Enterprises on the year before, so Cardinal Health grew faster. Cardinal Health kept 0.7% of its revenue as net profit, NU Skin Enterprises 10.8%. Free cash flow was $4.5B at Cardinal Health and $46M at NU Skin Enterprises.

Side by side, latest fiscal year

CAHNUS
Fiscal year endedFY2026 (June 30, 2026)FY2025 (December 31, 2025)
Revenue$254.2B$1.5B
Revenue growth+14.2%-14.3%
Net income$1.7B$160.2M
Net margin0.7%10.8%
Free cash flow$4.5B$46M
Free cash flow margin1.8%3.1%
Earnings per share (diluted)$7.23$3.18
Cash$4.9B$238.6M
Debt$8.9B$224.2M
Price to earnings30.51.5
Market value$51.2B$225.4M
Dividend yield0.93%n/a
Rank by revenue in sector#5 of 523 · Health care#122 of 523 · Health care

Over the years

Revenue
CAH FY2019: $145.5BCAH FY2020: $152.9BCAH FY2021: $162.5BCAH FY2022: $181.3BCAH FY2023: $205BCAH FY2024: $226.8BCAH FY2025: $222.6BCAH FY2026: $254.2BNUS FY2018: $2.7BNUS FY2019: $2.4BNUS FY2020: $2.6BNUS FY2021: $2.7BNUS FY2022: $2.2BNUS FY2023: $2BNUS FY2024: $1.7BNUS FY2025: $1.5BFY18FY19FY20FY21FY22FY23FY24FY25FY26
CAH $254.2BNUS $1.5B
Net income
CAH FY2019: $1.4BCAH FY2020: -$3.7BCAH FY2021: $611MCAH FY2022: -$938MCAH FY2023: $330MCAH FY2024: $852MCAH FY2025: $1.6BCAH FY2026: $1.7BNUS FY2018: $121.9MNUS FY2019: $173.6MNUS FY2020: $191.4MNUS FY2021: $147.3MNUS FY2022: $104.8MNUS FY2023: $8.6MNUS FY2024: -$146.6MNUS FY2025: $160.2MFY18FY19FY20FY21FY22FY23FY24FY25FY26
CAH $1.7BNUS $160.2M
Net margin
CAH FY2019: 0.9%CAH FY2020: -2.4%CAH FY2021: 0.4%CAH FY2022: -0.5%CAH FY2023: 0.2%CAH FY2024: 0.4%CAH FY2025: 0.7%CAH FY2026: 0.7%NUS FY2018: 4.5%NUS FY2019: 7.2%NUS FY2020: 7.4%NUS FY2021: 5.5%NUS FY2022: 4.7%NUS FY2023: 0.4%NUS FY2024: -8.5%NUS FY2025: 10.8%FY18FY19FY20FY21FY22FY23FY24FY25FY26
CAH 0.7%NUS 10.8%
Revenue growth
CAH FY2020: +5.1%CAH FY2021: +6.2%CAH FY2022: +11.6%CAH FY2023: +13.0%CAH FY2024: +10.7%CAH FY2025: -1.9%CAH FY2026: +14.2%NUS FY2019: -9.7%NUS FY2020: +6.7%NUS FY2021: +4.4%NUS FY2022: -17.4%NUS FY2023: -11.5%NUS FY2024: -12.0%NUS FY2025: -14.3%FY19FY20FY21FY22FY23FY24FY25FY26
CAH +14.2%NUS -14.3%
Free cash flow
CAH FY2019: $2.4BCAH FY2020: $1.6BCAH FY2021: $2BCAH FY2022: $2.8BCAH FY2023: $2.4BCAH FY2024: $3.3BCAH FY2025: $1.9BCAH FY2026: $4.5BNUS FY2018: $132.4MNUS FY2019: $111.9MNUS FY2020: $315.3MNUS FY2021: $73MNUS FY2022: $49MNUS FY2023: $60.1MNUS FY2024: $70.2MNUS FY2025: $46MFY18FY19FY20FY21FY22FY23FY24FY25FY26
CAH $4.5BNUS $46M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cardinal Health and NU Skin Enterprises

Which is bigger by revenue, Cardinal Health or NU Skin Enterprises?

Cardinal Health is bigger by revenue: $254.2B in fiscal 2026, against $1.5B for NU Skin Enterprises in fiscal 2025.

Which keeps more of its revenue as profit, Cardinal Health or NU Skin Enterprises?

Cardinal Health had a net margin of 0.7% in fiscal 2026; NU Skin Enterprises had 10.8% in fiscal 2025.

Which grew revenue faster, Cardinal Health or NU Skin Enterprises?

In their latest fiscal years revenue changed by +14.2% at Cardinal Health and -14.3% at NU Skin Enterprises.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies